세계 완제(Fill finish) 제조 시장 규모는 2023년 95억 9,289만 달러, 2030년에는 169억 4,787만 달러에 달할 것으로 예상되며, 2024-2030년의 예측 기간 동안 연평균 9.99%의 성장률을 보일 것으로 예상됩니다. 이 시장은 다양한 질병으로 인해 필피니시 제조 공정에 대한 수요가 증가하고 있으며, 인적 개입이 적고 오염 가능성이 적다는 점 등의 요인으로 인해 호황을 누릴 것으로 예상됩니다. 시장 내 기술 개발의 진전은 이 부문에서 진행되고 있는 인수합병과 함께 예측 기간(2024-2030년) 동안 시장 수익 성장에 큰 기여를 할 것으로 예상됩니다.
필 피니시 제조 시장 역학
필피니시 제조 시장의 주목할 만한 촉진요인은 종양, 신경, 코로나19 발병 등 다양한 질병의 유행으로 인한 최근 몇 년간 필피니시 제조에 대한 수요 증가 등입니다. 세계보건기구(WHO)(2023)에 따르면 매년 평균 40만 명의 어린이가 암에 걸린다고 합니다. 이 자료는 또한 폐암, 유방암, 대장암, 전립선암 등 2020년 전 세계적으로 1,000만 명이 암으로 사망했다고 밝혔습니다. 또한, WHO(2023)에 따르면 현재 약 5,500만 명이 치매를 앓고 있으며, 이 숫자는 2030년까지 7,800만 명, 2050년까지 1억 3,900만 명으로 늘어날 것으로 예측했습니다. 이러한 모든 질병은 환자의 생명 유지에 도움이 되는 치료제, 생물학적 제제 및 기타 약물의 형태로 의료 지원이 필요하기 때문에 향후 몇 년동안 필피니시 제조 시장에 대한 수요가 증가할 것으로 예상됩니다.
또한, 완제(Fill finish) 제조 시장에서 인수합병이 증가함에 따라 예측 기간 동안 고품질 의약품 및 장비에 대한 시장 수요가 증가할 것으로 예상됩니다. 예를 들어, 2020년 1월, 제약 및 생물학적 제제 산업을 위한 완전 통합형 맞춤형 엔드 투 엔드 맞춤형 솔루션을 제공하는 Alcami Corporation은 노스캐롤라이나에 위치한 최첨단 무균 필피니시 제조 센터 솔루션 업체인 TriPharm Services를 인수했습니다. 이러한 최근 몇 년간의 발전은 더 많은 사람들에게 필피니쉬 서비스를 확대하는 데 도움이 될 것이며, 그 결과 전체 완제(Fill finish) 제조 시장을 예측 기간 내에 발전시킬 것입니다.
그러나 필피니쉬 제품의 높은 비용, 숙련된 전문가 부족으로 인한 오염 가능성 증가 등으로 인해 저개발국 및 개발도상국에서는 완제(Fill finish) 제조의 채택 및 접근성이 낮아져 완제(Fill finish) 제조 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.
필피니시 제조 시장은 코로나19 팬데믹 기간 동안 큰 성장을 보였으며, 코로나19 확진자 증가로 인해 의약품 및 생물학적 제제에 대한 수요가 급격히 증가하여 생산량이 급증했습니다. 또한, 백신 개발을 위한 R&D 활동과 전 세계적으로 대규모 생산 요구사항이 시장 성장을 더욱 촉진했습니다. 또한, 광범위한 제조 시설 및 산업의 시작과 향후 추가 전염병을 예방하기 위한 집단 예방 접종을 위한 의약품 및 잠재적 생물학적 제제 생산에 대한 수요 증가는 2024-2030년의 예측 기간 동안 전체 필피니시 제조 시장을 견인할 것으로 예상됩니다.
필피니시 제조 시장 부문별 분석
필피니시 제조 시장의 제품 부문에서는 소모품 카테고리가 예측 기간(2024-2030년) 동안 전체 시장에서 큰 폭의 매출 성장을 기록할 것으로 예상됩니다.
이는 소모품 사용 증가, 향후 무균 상태를 유지하기 위한 새로운 소모품의 필요성, 제품 출시 형태의 기술 개발이 증가함에 따라 필피니시 제조 시장의 제품 부문에서 소모품에 대한 수요가 증가할 것으로 예상됩니다.
소모품에는 무균 상태를 유지하기 위해 한 번만 사용하고 폐기해야 하는 주사기, 바이알과 같은 유형의 기기가 포함됩니다. 동결 건조에서 바이알과 같은 소모품의 사용 증가와 생물학적 제제에서 일회용 포장의 사용 증가는 이 제품 부문이 필피니시 제조 시장 수요를 촉진하는 다양한 요인입니다.
이 보고서는 세계 필피니시 제조 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등을 전해드립니다.
Fill Finish Manufacturing Market By Product (Consumables [Prefilled Syringes, Vials, Cartridges, And Others], Instruments [By System Type {Integrated And Standalone}, By Machine Type {Automated, Semi-Automated And Manual}], By End-User (Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies, And Others), and by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to the growing demand for fill finish manufacturing, along with the rising technological advancement and merger acquisitions during the given forecast period.
The global Fill Finish Manufacturing Market was valued at USD 9,592.89 million in 2023, growing at a CAGR of 9.99% during the forecast period from 2024 to 2030 to reach USD 16,947.87 million by 2030. The Fill Finish Manufacturing Market is slated to witness prosperity owing to factors such as the growing demand for fill-finish manufacturing processes owing to a variety of diseases, requiring less human intervention and minimal chances of contamination. The rising technological developments in the fill-finish manufacturing market along with merger acquisitions taking place in the sector are further expected to result in appreciable revenue growth for the fill-finish manufacturing market during the forecast period (2024-2030).
Fill Finish Manufacturing Market Dynamics:
Among the noteworthy drivers of the fill-finish manufacturing market, is the rising demand for fill-finish manufacturing in recent times owing to the prevalence of a variety of diseases such as oncological and neurological, and the onset of COVID-19, among others. According to the World Health Organization (2023), 400,000 children develop cancer every year on average. The source further stated that cancer caused 10 million deaths worldwide in 2020, such as lung, breast, colon & rectum, and prostate cancer. Moreover, as per WHO (2023), around 55 million people are currently living with dementia, and this number is expected to rise to 78 million in 2030 and 139 million in 2050. All the given conditions would require medical assistance in the form of therapies, biologics, and other drugs that may be beneficial in sustaining the life of the patient, thus increasing the market demand for the fill-finish manufacturing market in the upcoming years.
Also, the rising merger acquisitions in the fill-finish manufacturing market are expected to spur the market demand for high-quality grade drugs and instruments during the forecast period. For instance, in January 2020, the Alcami Corporation, a provider of fully-integrated custom, end-to-end custom solutions for pharmaceutical and biologics industries acquired TriPharm Services, a new-state-of the-art sterile fill-finish manufacturing center solutions, located in North Carolina. Such recent developments help in the expansion of fill-finish services to be provided to a broader spectrum of people, thus driving the overall market for the fill-finish manufacturing market positively during the given forecast period.
However, the high costs of fill-finish products and increased chances of contamination with a lack of trained professionals and others would lead to less adoption and accessibility of fill-finish manufacturing by underdeveloped or developing countries, thus acting as restraints for the market growth of fill-finish manufacturing.
The fill-finish manufacturing market saw enormous growth during the period of COVID- 19 pandemic. Owing to the rising cases of COVID- 19, the demand and the immediate surge in the production of drugs and biologics exponentially increased. Moreover, the research and developmental activities to develop vaccines and their manufacturing requirement on a large scale worldwide, further pushed the growth of the fill-finish manufacturing market. In addition, the opening of widescale manufacturing units and industries, and the increasing demand for the production of drugs and potential biologics for mass immunization to prevent any further pandemics in the future, are expected to uplift the overall fill-finish manufacturing market during the forecast period from 2024-2030.
Fill Finish Manufacturing Market Segment Analysis:
Fill Finish Manufacturing Market by product (consumables [prefilled syringes, vials, cartridges, and others], instruments [by system type {integrated and standalone}, by machine type {automated, semi-automated and manual}], by end-user (contract manufacturing organizations, pharmaceutical & biopharmaceutical companies, and others), and geography (North America, Europe, Asia-Pacific, and Rest of the World)
Based on the product segment of the Fill Finish Manufacturing Market, the consumables category is projected to register a significant growth in revenue in the overall Fill Finish Manufacturing Market during the forecast period (2024-2030).
This can be ascribed to the increasing use of consumables, the subsequent need for new consumables to maintain sterile conditions, and the rising technological developments in the form of product launches are expected to drive the demand for consumables in the product segment of the fill-finish manufacturing market.
Consumables include various types of syringes, vials, and other types of equipment that can be only used once and need to be discarded, to maintain sterile conditions. The increasing use of consumables such as vials in lyophilization, and their growing use for disposable packaging in biologics are the various factors owing to which the product segment is driving the demand for the fill-finish manufacturing market.
Thereby, considering the growing demand for this segment, numerous new products are being launched in the market. For example, in October 2022, West Pharmaceutical introduced the DeltaCube Modeling Platform and NovaGaurd SA Pro Safety System for 0.5mL standard glass syringes at Interphex.
Therefore, considering the advantages and the wide applicability associated with the consumables category in the product segment, this segment is expected to generate considerable revenue thereby pushing the overall growth of the global Fill Finish Manufacturing Market during the forecast period.
Asia-Pacific is expected to register the fastest growth in CAGR in the Global Fill-Finish Manufacturing Market:
Among all the regions, Asia-Pacific is expected to register the fastest growth in CAGR in the global Fill Finish Manufacturing Market. This can be ascribed to factors such as the increasing investments by companies in clinical research, significant improvements in healthcare infrastructure, the growing construction of fill-finish facilities, and the rising product development activities in the region. For instance, in August 2022, Lonza added capacity at its biologics manufacturing facility in Guangzhou, China, by installing a new fill-finish line unit. In addition, with the costs of material and labor being comparatively cheaper in countries such as India and China, the manufacturing process of the fill-finish market becomes easy, thus driving the global market for the fill-finish manufacturing market. Along with this, the rapid expansion of the biopharmaceutical industry could be a major factor driving the demand for fill-finish manufacturing in the region.
Countries in the Asia-Pacific region such as India and China, being the largest exporters to western companies, have increased their production of APIs. For instance, in August 2020, Wockhardt Ltd, headquartered in Mumbai, India announced a deal with the U.K. government which would supply millions of doses of numerous COVID-19 vaccines, as well as those being formed by AstraZeneca and Oxford University. As part of the deal, the company had also confined fill-and-finish capacity, being the final production step of putting vaccines into syringes or vials and packaging them.
Therefore, the above-mentioned factors are expected to bolster the growth and register a significant CAGR in the Fill Finish Manufacturing Market in the Asia-Pacific region during the forecast period.
Fill Finish Manufacturing Market Key Players:
Some of the key market players operating in the Fill Finish Manufacturing Market include Becton, Dickinson and Company, Syntegon Technology GmbH, Industria Macchine Automatiche S.p.A., Stevanato Group, West Pharmaceutical Services, Inc., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger & Co. GmbH, Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, SGD Pharma, Schott AG, Nipro Corporation, Bausch Advanced Technology Group, VanRX Pharmasystems Inc., Aseptic Technologies, Reagent Chemical & Research Inc., AST, Steriline S.R.L, and others.
Recent Developmental Activities in the Fill-Finish Manufacturing Market:
In March 2022, SGD pharma launched its ready-to-use sterile 100 ml molded glass vials, which are used for fill finish parental drug products. These glass vials help in proper drug stability and eliminate the chances of scratch on vials to enhance visual inspection.
In February 2022, Moderna and Thermo Fisher scientific underwent long-term strategic collaboration to bolster the range of aseptic fill-finish manufacturing of Spikevax, Covid-19 vaccines, and different mRNA medicines in the US.
In October 2022, West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced the unveiling of its DeltaCube(TM) Modeling Platform as well as the new NovaGuard® SA Pro Safety System for ISO 0.5mL Standard Glass Syringes at Interphex.
Key Takeaways from the Fill-Finish Manufacturing Market Report Study
Target Audience who can be benefited from this Fill-Finish Manufacturing Market Report Study
Frequently Asked Questions for the Fill-Finish Manufacturing Market:
Fill Finish Manufacturing refers to the process of filling vials, syringes, and other storage types of equipment with the vaccine, biological & pharmaceutical drug substances along with proper packaging for mass distribution.
The global Fill Finish Manufacturing Market was valued at USD 9,592.89 million in 2023, growing at a CAGR of 9.99% during the forecast period from 2024 to 2030 to reach USD 16,947.87 million by 2030.
The Fill Finish Manufacturing market is slated to witness prosperity owing to factors such as the growing demand for fill-finish manufacturing processes, requiring less human intervention and minimal chances of contamination. The rising technological developments in the fill-finish manufacturing market along with merger acquisitions taking place in the sector are further expected to result in appreciable revenue growth for the fill-finish manufacturing market during the forecast period (2024-2030).
Some of the key market players operating in the Fill Finish Manufacturing Market include Becton, Dickinson and Company, Syntegon Technology GmbH, Industria Macchine Automatiche S.p.A., Stevanato Group, West Pharmaceutical Services, Inc., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger & Co. GmbH, Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, SGD Pharma, Schott AG, Nipro Corporation, Bausch Advanced Technology Group, VanRX Pharmasystems Inc., Aseptic Technologies, Reagent Chemical & Research Inc., AST, Steriline S.R.L, and others.
The Asia-Pacific region is expected to have the fastest-growing CAGR in the overall Fill Finish Manufacturing Market during the forecast period from 2024 to 2030. This can be ascribed to factors such as the increasing investments by companies in clinical research, significant improvements in healthcare infrastructure, the growing construction of fill-finish facilities, and the rising product development activities in the region.